Amgen





Ebit Cambio Fecha
AbbVie USD 5.81B 4.36B 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
ALKERMES USD 89.08M 3.9M 2025-09
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Coherus Biosciences USD -45.43M 3.19M 2025-03
Eli Lilly USD 8.99B 1.57B 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Genmab DKK 432M 900.27M 2025-06
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD -9.19B 13.87B 2025-06
Novartis USD 4.48B 343M 2025-09
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Takeda JPY 257.49B 568.56B 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Amgen - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.